Sign in

mariamabutair.bsky.social

@mariamabutair.bsky.social
39 followers 96 following 3 posts

❤️ for nephrology, internal medicine, icu! 📚🎼🎹🧳🚵‍♀️🎿🥾

PostsRepliesMedia
Reposted by @mariamabutair.bsky.social
kireports.bsky.social @kireports.bsky.social · 18/05/2026
Development and Validation of a #Cystatin C-based #Staging of #AKI in Critically Ill Patients #VisualAbstract by @Husamjz www.kireports.org/article/S2468-024…
031
Reposted by @mariamabutair.bsky.social
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 08/05/2026
Are you still interested in contrast and AKI? @markusathome.bsky.social and @gunnarheine.bsky.social invited me to pontificate Watch it here youtu.be/ZhJTKnm8iZg #NephSky
youtu.be
CM-induced AKI: Myth or Reality? Prof. Dr. Swapnil Hiremath (Ottawa, Canada)
YouTube video by MARKUS at HOMe
2229
Reposted by @mariamabutair.bsky.social
Brian Rifkin @brianrifkin.bsky.social · 02/05/2026
🚨A new KI Reports Community blog about Obinutuzumab. Wonderful review of how it differs from other anti-CD20 treatments, worth a read 📖 By Dr. Priyadarshini John #NephSky #MedSky www.kireportscommunity.org/post/beyond-...
kireportscommunity.org
Beyond Rituximab: Obinutuzumab Redefines Treatment in Resistant Membranous Nephropathy
Written by Priyadarshini John, DMPrimary membranous nephropathy (MN) is a prototypical autoimmune glomerular disease and one of the most common causes of nephrotic syndrome in adults. The discovery of...
084
Reposted by @mariamabutair.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 01/05/2026
Latest Editorial—Diabetes-related complications: an evolving spectrum thelancet.com/journals/lan... #diabetes #complications #FREE to read #MedSky #EndoSky
thelancet.com
Diabetes-related complications: an evolving spectrum
The burden of diabetes-related complications continues to rise globally, exerting a huge toll on individuals, health-care systems, and economies, particularly in low-income and middle-income countries...
001
Reposted by @mariamabutair.bsky.social
Joel Topf @kidneyboy.bsky.social · 28/04/2026
You ever read a title and feel it reach through your consciousness, tap you on the shoulder, and whisper, "It's all been worth it. Expertise matters."
1134
Reposted by @mariamabutair.bsky.social
American Journal of Kidney Diseases @ajkd.bsky.social · 17/02/2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD bit.ly/49qlTTE #OpenAccess
011
Reposted by @mariamabutair.bsky.social
Dominique Guerrot @dguerrot.bsky.social · 11/02/2026
🙋‍♀️🙋‍♂️ Help shape practice on hypertension in ADPKD! 🔎 An ERKNet survey for adult & pediatric nephrologists, based on a PKD France initiative with support by ERA Kidney & Genes WG and ESPN 🇪🇺 Many thanks for your input ! Dominique Guerrot & Djalila Mekahli
surveymonkey.com
ERKNet Survey | Blood Pressure Management in ADPKD - A European Survey of Clinical Practice
Take this survey powered by surveymonkey.com. Create your own surveys for free.
037
Reposted by @mariamabutair.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 14/02/2026
Diabetic ketoacidosis (#DKA) is an acute complication associated mainly with type 1 #diabetes, but can occur in type 2 & other forms of diabetes, & is one of the most preventable causes of morbidity and mortality for individuals with diabetes www.thelancet.com/journals/lan... #T1D #T2D #FREE w/reg
thelancet.com
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
The ability to reduce the risk of developing diabetic ketoacidosis (DKA) remains a major care gap for people with diabetes, particularly those on intensive insulin therapy. The anticipated availabilit...
082
Reposted by @mariamabutair.bsky.social
JAMA @jama.com · 09/02/2026
Moderate consumption of caffeinated coffee or tea was linked to reduced #dementia risk and modest improvements in cognitive outcomes; no benefit was seen for decaffeinated coffee in an observational study of US adults. bit.ly/4bEUa2F
Line graph titled 'Incident dementia' shows hazard ratio (95% CI) vs. caffeinated coffee intake. The curve starts at 1.0, declines until about 3 c/d intake, then slightly rises. Intake c/d ranges from 0 to >5. No. of cases and person-years are also provided.
22015
Reposted by @mariamabutair.bsky.social
The Lancet @thelancet.com · 03/01/2026
By 2050, chronic kidney disease (CKD) is projected to become the fifth leading underlying cause of death worldwide. A new Seminar provides a simple approach to CKD diagnosis, staging, and management that can be applied in most clinical settings: spkl.io/63323AlsFF
Figure showing specialist nephrology management of chronic kidney disease. Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
1127
Reposted by @mariamabutair.bsky.social
Rolando Claure @runningkidneys.bsky.social · 02/01/2026
Non-tunneled vs tunneled HD catheters: a 301-patient study found no significant difference in CRBSI rates with pre-curved non-tunneled catheters vs tunneled. Suggests longer use may be reasonable while awaiting AVF/PD cath/transplant. doi.org/10.1093/ckj/...
doi.org
Comparable rates of catheter-related bloodstream infections between non-tunneled and tunneled hemodialysis catheters: a retrospective single-center study
AbstractBackground. A hemodialysis catheter may serve as a short- or medium-term vascular access solution. Current guidelines suggest restricting non-tunne
001
Reposted by @mariamabutair.bsky.social
markusathome @markusathome.bsky.social · 02/01/2026
It's that time again! Nephrology/Hypertension – Top Studies 2025, Part 1! youtu.be/n3aBxK013bY?... @gunnarheine.bsky.social @mariamabutair.bsky.social @kronbichlerlab.bsky.social @marcussaemann.bsky.social @sarahelektra.bsky.social
youtu.be
Nephrologie / Hypertensiologie 2025 I
YouTube video by MARKUS at HOMe
075
Reposted by @mariamabutair.bsky.social
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 17/12/2025
We really don’t think BigPAK makes sense From our journal club at @uottawa.ca into a #NephJC shorts www.nephjc.com/news/2025/12...
nephjc.com
BigPAK or a bundle of balderdash? — NephJC
We break down the latest salvo from Zarbock et al on a supposedly wonderful ‘bundle’
2125
Reposted by @mariamabutair.bsky.social
Nephrology Journal Club @nephjc.bsky.social · 12/12/2025
11/10 Up next 12/16/25 we’re talking about AKI and best strategies for renal recovery from dialysis #nephjc LIBERATE-D, simultaneous @jama.com publication during #KidneyWk pubmed.ncbi.nlm.nih.gov/41201895/
pubmed.ncbi.nlm.nih.gov
A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial - PubMed
ClinicalTrials.gov Identifier: NCT04218370.
023
Reposted by @mariamabutair.bsky.social
ASN Publications @asnpublications.bsky.social · 12/12/2025
Many people with CKD are unaware of the condition. This #ASNKidney360 article investigates time to diagnosis in the US using electronic health records-linked retrospective claims data. Read more: kidney.pub/KID1056
001
Reposted by @mariamabutair.bsky.social
JAMA @jama.com · 24/11/2025
Continuous glucose monitoring (CGM) enables real-time assessment of glucose trends in individuals with type 2 #diabetes, complementing or replacing fingerstick and HbA1c monitoring. 💡 This JAMA Insights discusses CGM use for type 2 diabetes. ja.ma/4ogw8xz
JAMA Insights: Continuous Glucose Monitoring, published November 24, 2025. The image shows glucose monitoring data, including time in ranges, glucose metrics, ambulatory glucose profile (AGP), and daily glucose profiles.
095
Reposted by @mariamabutair.bsky.social
Cristina Popa @nephroseeker.medsky.social · 25/11/2025
Probably #nephsky will never see a trial comparing spironolactone with finerenone Target emulated trial: potential benefits of finerenone in all sorts of outcomes, but we’re comparing 🔝methodology trials (FIGARO, FIDELIO) vs invetigator initiated trials pubmed.ncbi.nlm.nih.gov/41173939/
372
Reposted by @mariamabutair.bsky.social
NDT @ndt-era.bsky.social · 25/11/2025
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents doi.org/10.1093/ndt/...
doi.org
Nephrotoxicity of Conventional Chemotherapeutics: Part I — Platinum Compounds and Antimetabolite Agents
Abstract. Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventiona
001
Reposted by @mariamabutair.bsky.social
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 04/11/2025
From @carolyntan.bsky.social This is a work of art Have to agree that amlodipine and gabapentin/pregabalin often lead to heart failure misdiagnosis #MedSky #PharmSky h/t @davidjuurlink.bsky.social and @jbrianbyrd.bsky.social
Description of a prescription cascade, when an initial prescription for pregabalin or amlodipine causes leg oedema leading to addition of furosemide which causes urinary incontinence. This leads to a RX for Solifenacin which causes cognitive decline and a prescription for Don Pascale. The subsequent anorexia and an insomnia leads to mirtazapine prescription and a hip fracture from a fall. This of course leads to many other cascades, including delirium, haloperidol and levodopa, risedronate, and pantoprazole, or iron and constipation with peg.
3165
Reposted by @mariamabutair.bsky.social
Nephro Intensiv Berlin @nephrointberlin.bsky.social · 16/10/2025
It was a pleasure organizing our 5th course on Intensive Care Nephrology together with Nicole Bethke, Martin Kuhlmann and the Akademie Niere. Inspiring lectures and an outstanding group of participants! #nephsky #nephrology
122
Reposted by @mariamabutair.bsky.social
ASN Publications @asnpublications.bsky.social · 08/10/2025
In three trials, finerenone reduced a range of cardiovascular and kidney outcomes in persons with diabetes and CKD. Read more in #ASNJASN: kidney.pub/JASN0823
031
Reposted by @mariamabutair.bsky.social
Deutsche Gesellschaft für Nephrologie e.V. (DGfN) @dgfn.bsky.social · 25/09/2025
More precise diagnoses, a new guideline and targeted therapies: Glomerulonephritis care is changing. Key topic at the DGfN Annual Meeting 2025 in Berlin. Read more👉 bit.ly/4pwUxkc #Nephrology #CKD
Graphic for the Nephrology 2025 annual meeting of the German Society of Nephrology. Text: ‘Progress in glomerulonephritis: more precise diagnoses, targeted innovative therapies and new guideline improve care.’ Below: ‘Nephrology 2025 – 17th Annual Meeting of the DGfN, October 2–5, 2025, Estrel Congress Center Berlin.’ Design in blue and green tones with logo.
032
Reposted by @mariamabutair.bsky.social
markusathome @markusathome.bsky.social · 05/09/2025
It's Congress-Update time! Check out our new webinar "Post ESC 2025"! youtu.be/6C6lJWUHlc8?...
youtu.be
Post ESC 2025
YouTube video by MARKUS at HOMe
054
Reposted by @mariamabutair.bsky.social
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 05/09/2025
How common is kidney failure with MCD and FSGS? More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...
Visual abstract
2135
Reposted by @mariamabutair.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 24/08/2025
We propose that drug-induced weight loss is largely responsible for the reported improvements in osteoarthritis, obstructive sleep apnoea, and metabolic dysfunction-associated steatohepatitis outcomes www.thelancet.com/journals/lan... #weightloss #GLP-1 receptor agonists #MedSky #EndoSky#LiverSky
thelancet.com
Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct effects of these drugs is the subject of intense interest. Although reductions in...
011
Reposted by @mariamabutair.bsky.social
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 15/08/2025
Spironolactone does not work for dialysis ACHIEVE published in @thelancet.com @lastwalsh.bsky.social and colleagues www.thelancet.com/journals/lan... Coming soon to a #NephJC near you
thelancet.com
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial
Among patients receiving maintenance dialysis, spironolactone 25 mg daily orally did not reduce the composite outcome of cardiovascular mortality and hospitalisation due to heart failure compared with...
53119
Reposted by @mariamabutair.bsky.social
ASN Publications @asnpublications.bsky.social · 29/07/2025
Peritoneal dialysis (PD) is not often used for patients with Autosomal dominant polycystic kidney disease (ADPKD). This #ASNKidney360 research demonstrates that PD is safe and effective for patients with ADPKD. Read more: kidney.pub/KID0888
001
Reposted by @mariamabutair.bsky.social
Nature Reviews Nephrology @natrevneph.nature.com · 24/07/2025
ICYMI:
nature.com
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
001
Reposted by @mariamabutair.bsky.social
Critical Care Reviews @criticalcarereviews.com · 21/07/2025
Expanding the boundaries of kidney replacement therapy in patients with liver failure CCR Journal Watch - tracking the critical care literature daily criticalcarereviews.com/latest-evid…
001
Reposted by @mariamabutair.bsky.social
NEJM.org @nejm.org · 21/07/2025
In the PREDMETH trial, first-line treatment of pulmonary sarcoidosis with methotrexate was noninferior to that with prednisone regarding the change at 24 weeks in the percentage of the predicted forced vital capacity. Full trial results and Research Summary: nej.md/4kdaf0o #MedSky #PulmSky
The New England Journal of Medicine               
Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate 
A Research Summary based on Kahlmann V et al. | 10.1056/NEJMoa2501443 | Published on May 18, 2025 

Visual representations of the patients in the trial and the treatments they were assigned.                   

Read the full Research Summary at NEJM.org.
0116
Reposted by @mariamabutair.bsky.social
Nature Reviews Nephrology @natrevneph.nature.com · 18/07/2025
nature.com
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
096
Reposted by @mariamabutair.bsky.social
ISNkidneycare @theisn.org · 30/06/2025
A new conceptual review for Secondary Membranous Nephropathy Always think broader when the puzzle doesn’t fit perfectly. #ECNeph @dramiliflores.bsky.social @karnephro.bsky.social www.emjreviews.com/w...
011
Reposted by @mariamabutair.bsky.social
Critical Care Reviews @criticalcarereviews.com · 29/06/2025
Today's Paper of the Day is: Demystifying Volume Status. An Ultrasound-Guided Physiologic Framework. criticalcarereviews.com/latest-evid… Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025
022
Reposted by @mariamabutair.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 29/06/2025
By re-evaluating current definitions, acknowledging the progressive nature of type 2 #diabetes, and embracing individualised approaches to glycaemic control, #remission can be redefined as a dynamic continuum rather than a static endpoint www.thelancet.com/journals/lan... #T2D #MedSky #EndoSky
thelancet.com
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
Controlling weight and cardiovascular risk factors is paramount in type 2 diabetes management; however, the definition and feasibility of remission warrant closer examination. Type 2 diabetes remissio...
001
Reposted by @mariamabutair.bsky.social
Gunnar Heine @gunnarheine.bsky.social · 13/06/2025
Best of ERA 25 @markusathome.bsky.social with @lonniepyne.bsky.social @lastwalsh.bsky.social Dr. Stel Dr. Staplin Dr. Mann Dr. Fakhouri @rosertorra.bsky.social @katestevens.bsky.social @marcussaemann.bsky.social @sarahelena.bsky.social @dgfn.bsky.social @sfndt.bsky.social youtu.be/HbUEh8oLB2M?...
youtu.be
62nd ERA Congress - Profs. L. Pyne, F. Fakhouri, M. Walsh, H. Mann, N. Staplin, V. Stel & J. Barratt
YouTube video by MARKUS at HOMe
054
Reposted by @mariamabutair.bsky.social
Deutsche Gesellschaft für Nephrologie e.V. (DGfN) @dgfn.bsky.social · 05/06/2025
Post-ERA 2025 webinar on 13 June at 7:15 pm! Late-Breaker on kidney diseases in focus - with top researchers, including on IgAN, C3G, MRA & transplantation. Make a note now! 👉MARKUS at HOMe: www.youtube.com/watch?v=Q6WP...
youtube.com
Post ERA 2025 - NDT / MARKUS at HOMe Special
YouTube video by MARKUS at HOMe
162
Reposted by @mariamabutair.bsky.social
Gunnar Heine @gunnarheine.bsky.social · 09/06/2025
youtu.be/s-iglqVIp2s?... With @marcussaemann.bsky.social @sarahelena.bsky.social @rosertorra.bsky.social Prof. Anders Prof. Stevens
youtu.be
Post ERA 2025 - NDT / MARKUS at HOMe Special
YouTube video by MARKUS at HOMe
143
Reposted by @mariamabutair.bsky.social
Rolando Claure @runningkidneys.bsky.social · 05/06/2025
In the CONFIDENCE trial, combo therapy with #finerenone + #empagliflozin led to a >50% reduction in albuminuria over 180 days in patients with #CKD & #T2D — significantly greater than either drug alone. Safe, effective, synergistic. 👉 www.nejm.org/doi/full/10....
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa2410659
012
Reposted by @mariamabutair.bsky.social
Rolando Claure @runningkidneys.bsky.social · 05/06/2025
🔍 New meta-analysis of 1.8M+ patients shows even mild or short-duration AKI significantly increases risk of CKD, kidney failure & MAKE. ➡️ AKI stage 1: HR 1.49 for CKD ➡️ AKI <3 days: OR 2.37 for CKD 📢 Time to prioritize post-AKI kidney protection! doi.org/10.1093/ndt/...
001
Reposted by @mariamabutair.bsky.social
markusathome @markusathome.bsky.social · 30/05/2025
It's time for a new update on kidney transplantation with Prof. Böhmig! youtu.be/qlgBwc6g4rQ?...
youtu.be
Update Nierentransplantation 2025 - Prof. Dr. Georg Böhmig (Wien, Österreich)
YouTube video by MARKUS at HOMe
022
Reposted by @mariamabutair.bsky.social
American Journal of Hypertension @amjhypertension.bsky.social · 29/05/2025
Increased nighttime SBP is a more critical factor than hyperglycemia in affecting retinal vascular caliber changes in newly diagnosed T2DM patients 🔗 academic.oup.com/ajh/article/... 🔒
012
Reposted by @mariamabutair.bsky.social
American Journal of Kidney Diseases @ajkd.bsky.social · 29/05/2025
Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis bit.ly/Shroff25OI @alexchangmd.bsky.social‬ #CKD #VisualAbstract
032
Reposted by @mariamabutair.bsky.social
American Journal of Kidney Diseases @ajkd.bsky.social · 28/05/2025
This Core Curriculum by Kevin Bryan et al explores commonly implicated pathophysiological mechanisms in kidney dysfunction in heart failure and discuss the principles behind effective decongestion and assessment of adequacy of natriuresis: bit.ly/434spfa (FREE)
021
Reposted by @mariamabutair.bsky.social
NDT @ndt-era.bsky.social · 28/05/2025
Long-term risks of adverse kidney outcomes after acute kidney injury: a systematic review and meta-analysis doi.org/10.1093/ndt/...
031
Reposted by @mariamabutair.bsky.social
American Journal of Hypertension @amjhypertension.bsky.social · 27/05/2025
Prevalence and Outcomes of #Hypertension subtypes (isolated systolic/diastolic or sys-dias hypertension) from the #NHANES data 🔗 academic.oup.com/ajh/article-... 🔒
072
Reposted by @mariamabutair.bsky.social
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 25/05/2025
Advancements in gut–bone axis research could revolutionise treatment approaches for #bone disease, allowing individuals to experience the benefits of weight loss while minimising risks to #skeletal health www.thelancet.com/journals/lan... #incretins #osteoporosis #MedSky #EndoSky #RheumSky
thelancet.com
The gut–bone axis: implications of gut hormone-based therapies for bone health
Historical trends and future projections of the number of people with overweight and obesity suggest alarming parallel increases in serious and potentially fatal comorbidities, particularly type 2 dia...
002
Reposted by @mariamabutair.bsky.social
The Lancet Rheumatology @thelancetrheum.bsky.social · 23/05/2025
NEW for #LUPUS2025—ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic #lupus erythematosus manifestations bit.ly/3YXEmAO #SLE #Medsky #Rheumsky Free to read with registration on lancet.com (also free)
054
Reposted by @mariamabutair.bsky.social
Nature Reviews Nephrology @natrevneph.nature.com · 24/05/2025
We look forward to better integration of kidney disease into the NCD global public health agenda and hope that it will be recognized as a key driver of premature mortality, alongside cardiovascular disease, diabetes, cancer, chronic lung disease and mental illness. www.nature.com/articles/s41...
nature.com
Chronic kidney disease and the global public health agenda: an international consensus - Nature Reviews Nephrology
Addressing the burden of non-communicable diseases is a global public health priority. In this joint Consensus Statement, the American Society of Nephrology, the European Renal Association and the Int...
011
Reposted by @mariamabutair.bsky.social
Kidney International @kidneyint.bsky.social · 22/05/2025
The Mayo #MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a #kidneybiopsy in patients with #monoclonalgammopathy doi.org/10.1016/j.kint.2025.04.018 #NephSky #MedSky #renalbiopsy @mayoclinic.org
044
mariamabutair.bsky.social @mariamabutair.bsky.social · 22/05/2025
🫣
010